Working alongside her father, a semi-retired pharmacist to formulate the products, Pip applied her clever marketing chops to ...
The New Jersey-based Sun Pharmaceutical Industries, Inc is recalling 9,840 bottles of Morphine Sulfate extended-release ...
Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...
Ever-Growing USA on MSN1d
Packaging Production Line: A Comprehensive GuideIn the ever-evolving world of manufacturing and packaging, efficiency, precision, and innovation drive the industry forward.
President Donald Trump's blunt-force use of tariffs has forged a rare bipartisan alliance among Kentucky's top leaders — ...
Gold has exceeded $3,000 a troy ounce for the first time ever on economic uncertainty and safe-haven demand. Stock Futures Gain After Shutdown Averted With the threat of a government shutdown receding ...
Elite, a specialty pharmaceutical company developing niche generic products, has shipped its first lot of finished product ...
AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...
Science reveals there are a few reasons pharmacists don’t just send you home with any old color bottle. Here are four main ...
Adragos Pharma has completed a €4M project to install and commission a liquid filling line and accompanying cartoning machine ...
Glenmark Pharmaceuticals, an India-based drug manufacturer has issued a voluntary recall affecting nearly 1.48 million bottles of atomoxetine, a generic medication used to treat ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results